|
1
|
Mansell JP, Tarlton JF and Bailey AJ:
Biochemical evidence for altered subchondral bone collagen
metabolism in osteoarthritis of the hip. Br J Rheumatol. 36:16–19.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bobinac D, Marinovic M, Bazdulj E,
Cvijanovic O, Celic T, Maric I, Spanjol J and Cicvaric T:
Microstructural alterations of femoral head articular cartilage and
subchondral bone in osteoarthritis and osteoporosis. Osteoarthritis
Cartilage. 21:1724–1730. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kwan Tat S, Pelletier JP, Lajeunesse D,
Fahmi H, Lavigne M and Martel-Pelletier J: The differential
expression of osteoprotegerin (OPG) and receptor activator of
nuclear factor kappaB ligand (RANKL) in human osteoarthritic
subchondral bone osteoblasts is an indicator of the metabolic state
of these disease cells. Clin Exp Rheumatol. 26:295–304.
2008.PubMed/NCBI
|
|
4
|
Tat SK, Pelletier JP, Lajeunesse D, Fahmi
H, Duval N and Martel-Pelletier J: Differential modulation of RANKL
isoforms by human osteoarthritic subchondral bone osteoblasts:
Influence of osteotropic factors. Bone. 43:284–291. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Orth P, Cucchiarini M, Kaul G, Ong MF,
Gräber S, Kohn DM and Madry H: Temporal and spatial migration
pattern of the subchondral bone plate in a rabbit osteochondral
defect model. Osteoarthritis Cartilage. 20:1161–1169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roman-Blas JA and Herrero-Beaumont G:
Targeting subchondral bone in osteoporotic osteoarthritis.
Arthritis Res Ther. 16:4942014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li G, Yin J, Gao J, Cheng TS, Pavlos NJ,
Zhang C and Zheng MH: Subchondral bone in osteoarthritis: Insight
into risk factors and microstructural changes. Arthritis Res Ther.
15:2232013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Effendy NM, Khamis MF and Shuid AN: The
effects of Labisia pumila extracts on bone microarchitecture of
ovariectomized-induced osteoporosis rats: A micro-CT analysis. J
XRay Sci Technol. 25:101–112. 2017.PubMed/NCBI
|
|
9
|
Permuy M, Guede D, López-Peña M, Muñoz F,
Caeiro JR and González-Cantalapiedra A: Effects of diacerein on
cartilage and subchondral bone in early stages of osteoarthritis in
a rabbit model. BMC Vet Res. 11:1432015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mohan G, Perilli E, Kuliwaba JS, Humphries
JM, Parkinson IH and Fazzalari NL: Application of in vivo
micro-computed tomography in the temporal characterisation of
subchondral bone architecture in a rat model of low-dose monosodium
iodoacetate-induced osteoarthritis. Arthritis Res Ther.
13:R2102011. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bellido M, Lugo L, Roman-Blas JA,
Castañeda S, Caeiro JR, Dapia S, Calvo E, Largo R and
Herrero-Beaumont G: Subchondral bone microstructural damage by
increased remodelling aggravates experimental osteoarthritis
preceded by osteoporosis. Arthritis Res Ther. 12:R1522010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou J, Ma XN, Gao YH, Yan JL, Shi WG,
Xian CJ and Chen KM: Sinusoidal electromagnetic fields promote bone
formation and inhibit bone resorption in rat femoral tissues in
vitro. Electromagn Biol Med. 35:75–83. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang LQ, He HC, He CQ, Chen J and Yang L:
Clinical update of pulsed electromagnetic fields on osteoporosis.
Chin Med J (Engl). 121:2095–2099. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Janckila AJ and Yam LT: Biology and
clinical significance of tartrate-resistant acid phosphatases: New
perspectives on an old enzyme. Calcif Tissue Int. 85:465–483. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Suchecki D and Tufik S: Social stability
attenuates the stress in the modified multiple platform method for
paradoxical sleep deprivation in the rat. Physiol Behav.
68:309–316. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bolon B, Grisanti M, Villasenor K, Morony
S, Feige U and Simonet WS: Generalized Degenerative Joint Disease
in Osteoprotegerin (Opg) Null Mutant Mice. Vet Pathol. 52:873–882.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen Y, Jiang T, Wang R, He S, Guo M, Zuo
J and He D: (5R)-5-Hydroxytriptolide (LLDT-8) inhibits
osteoclastogenesis via RANKL/RANK/OPG signaling pathway. BMC
Complement Altern Med. 15:772015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Trouvin AP and Goëb V: Receptor activator
of nuclear factor-κB ligand and osteoprotegerin: Maintaining the
balance to prevent bone loss. Clin Interv Aging. 5:345–354.
2010.PubMed/NCBI
|
|
19
|
Lange U, Dischereit G, Tarner I, Frommer
K, Neumann E, Müller-Ladner U and Kürten B: The impact of serial
radon and hyperthermia exposure in a therapeutic adit on pivotal
cytokines of bone metabolism in rheumatoid arthritis and
osteoarthritis. Clin Rheumatol. 35:2783–2788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aida Y, Maeno M, Suzuki N, Shiratsuchi H,
Motohashi M and Matsumura H: The effect of IL-1beta on the
expression of matrix metalloproteinases and tissue inhibitors of
matrix metalloproteinases in human chondrocytes. Life Sci.
77:3210–3221. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Teitelbaum SL: Bone resorption by
osteoclasts. Science. 289:1504–1508. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liao N, Huang Y, Ye J, Chen W, Li ZF, Lin
R, Li X, Zheng L and Liu X: Protective effects of Tougu Xiaotong
capsule on tumor necrosis factor-α-injured UMR-106 cells. Exp Ther
Med. 10:1908–1914. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen S, Huang Y, Chen W, Wu G, Liao N, Li
X, Huang M, Lin R, Yu C, Li X, et al: Protective effects of the
Tougu Xiaotong capsule on morphology and osteoprotegerin/nuclear
factor-κB ligand expression in rabbits with knee osteoarthritis.
Mol Med Rep. 13:419–425. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng CS, Ye HZ, Xu XJ and Liu XX:
Computational pharmacology study of tougu xiaotong granule in
preventing and treating knee osteoarthritis. Chin J Integr Med.
15:371–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin MN and Liu XX: Observation of Tougu
Xiaotong Recipe for the treatment of 30 patients with knee
osteoarthritis. Fujian J Tradit Chin Med Chin. 36:15–16. 2005.(In
Chinese).
|
|
26
|
Li XH, Wu MX, Ye HZ, Chen WL, Lin JM,
Zheng LP and Liu XX: Experimental study on the suppression of
sodium nitroprussiate-induced chondrocyte apoptosis by Tougu
Xiaotong Capsule -containing serum. Chin J Integr Med. 17:436–443.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li X, Lang W, Ye H, Yu F, Li H, Chen J,
Cai L, Chen W, Lin R, Huang Y, et al: Tougu Xiaotong capsule
inhibits the tidemark replication and cartilage degradation of
papain-induced osteoarthritis by the regulation of chondrocyte
autophagy. Int J Mol Med. 31:1349–1356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu XX, Li XH and Zhou JT: [Experimental
study on replicating knee osteoarthritis by modified Hulth's
modeling method]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 25:1104–1108.
2005.(In Chinese). PubMed/NCBI
|
|
29
|
Mankin HJ, Dorfman H, Lippiello L and
Zarins A: Biochemical and metabolic abnormalities in articular
cartilage from osteo-arthritic human hips. II. Correlation of
morphology with biochemical and metabolic data. J Bone Joint Surg
Am. 53:523–537. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cox LG, van Donkelaar CC, van Rietbergen
B, Emans PJ and Ito K: Decreased bone tissue mineralization can
partly explain subchondral sclerosis observed in osteoarthritis.
Bone. 50:1152–1161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu S, Chen K, Lan Y, Zhang N, Jiang R and
Hu J: Alendronate protects against articular cartilage erosion by
inhibiting subchondral bone loss in ovariectomized rats. Bone.
53:340–349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Geusens PP and van den Bergh JP:
Osteoporosis and osteoarthritis: Shared mechanisms and
epidemiology. Curr Opin Rheumatol. 28:97–103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matsuo K and Irie N: Osteoclast-osteoblast
communication. Arch Biochem Biophys. 473:201–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Havill LM, Hale LG, Newman DE, Witte SM
and Mahaney MC: Bone ALP and OC reference standards in adult
baboons (Papio hamadryas) by sex and age. J Med Primatol.
35:97–105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ni J, Yuan XM, Yao Q and Peng LB: OSM is
overexpressed in knee osteoarthritis and Notch signaling is
involved in the effects of OSM on MC3T3-E1 cell proliferation and
differentiation. Int J Mol Med. 35:1755–1760. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bellido M, Lugo L, Roman-Blas JA,
Castañeda S, Calvo E, Largo R and Herrero-Beaumont G: Improving
subchondral bone integrity reduces progression of cartilage damage
in experimental osteoarthritis preceded by osteoporosis.
Osteoarthritis Cartilage. 19:1228–1236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ross PD, Kress BC, Parson RE, Wasnich RD,
Armour KA and Mizrahi IA: Serum bone alkaline phosphatase and
calcaneus bone density predict fractures: A prospective study.
Osteoporos Int. 11:76–82. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kong YY, Yoshida H, Sarosi I, Tan HL,
Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G,
Itie A, et al: OPGL is a key regulator of osteoclastogenesis,
lymphocyte development and lymph-node organogenesis. Nature.
397:315–323. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hofbauer LC and Schoppet M: Clinical
implications of the osteoprotegerin/RANKL/RANK system for bone and
vascular diseases. JAMA. 292:490–495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Whyte MP, Obrecht SE, Finnegan PM, Jones
JL, Podgornik MN, McAlister WH and Mumm S: Osteoprotegerin
deficiency and juvenile Paget's disease. N Engl J Med. 347:175–184.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brzóska MM and Rogalska J: Protective
effect of zinc supplementation against cadmium-induced oxidative
stress and the RANK/RANKL/OPG system imbalance in the bone tissue
of rats. Toxicol Appl Pharmacol. 272:208–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gurban CV and Mederle O: The OPG/RANKL
system and zinc ions are promoters of bone remodeling by osteoblast
proliferation in postmenopausal osteoporosis. Rom J Morphol
Embryol. 52:1113–1119. 2011.PubMed/NCBI
|
|
43
|
Fujii T, Kitaura H, Kimura K, Hakami ZW
and Takano-Yamamoto T: IL-4 inhibits TNF-α-mediated osteoclast
formation by inhibition of RANKL expression in TNF-α-activated
stromal cells and direct inhibition of TNF-α-activated osteoclast
precursors via a T-cell-independent mechanism in vivo. Bone.
51:771–780. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Onal M, Xiong J, Chen X, Thostenson JD,
Almeida M, Manolagas SC and O'Brien CA: Receptor activator of
nuclear factor κB ligand (RANKL) protein expression by B
lymphocytes contributes to ovariectomy-induced bone loss. J Biol
Chem. 287:29851–29860. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Riegel A, Maurer T, Prior B, Stegmaier S,
Heppert V, Wagner C and Hänsch GM: Human polymorphonuclear
neutrophils express RANK and are activated by its ligand, RANKL.
Eur J Immunol. 42:975–981. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim KW, Kim HR, Park JY, Park JS, Oh HJ,
Woo YJ, Park MK, Cho ML and Lee SH: Interleukin-22 promotes
osteoclastogenesis in rheumatoid arthritis through induction of
RANKL in human synovial fibroblasts. Arthritis Rheum. 64:1015–1023.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lam J, Takeshita S, Barker JE, Kanagawa O,
Ross FP and Teitelbaum SL: TNF-alpha induces osteoclastogenesis by
direct stimulation of macrophages exposed to permissive levels of
RANK ligand. J Clin Invest. 106:1481–1488. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Onal M, Galli C, Fu Q, Xiong J, Weinstein
RS, Manolagas SC and O'Brien CA: The RANKL distal control region is
required for the increase in RANKL expression, but not the bone
loss, associated with hyperparathyroidism or lactation in adult
mice. Mol Endocrinol. 26:341–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zeng JZ, Ma LF, Meng H, Yu HM, Zhang YK
and Guo A: (5R)-5-hydroxytriptolide (LLDT-8) prevents
collagen-induced arthritis through OPG/RANK/RANKL signaling in a
rat model of rheumatoid arthritis. Exp Ther Med. 12:3101–3106.
2016. View Article : Google Scholar : PubMed/NCBI
|
